CRS: Whitman-Walker
Position: Pharmacist of Record
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
